Literature DB >> 9579581

Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung.

T Asai1, T Ueda, K Itoh, K Yoshioka, Y Aoki, S Mori, H Yoshikawa.   

Abstract

We established a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung from murine Dunn osteosarcoma using 8 repeated Fidler's procedures. We performed the biological characterization of the LM8 and the maternal Dunn cell lines in vitro and in vivo. Morphologically, LM8 possesses many fillopodial protrusions, lamellipodial structures surrounding the cell surface and membrane ruffles suggesting enhanced cell motility. The increased matrix metalloproteinase (MMP) 2 activity of this cell line might help cell invasion after penetration of the endothelial (mesothelial) cell layer. This cell line exhibited high in vitro invasive activity when seeded onto the mesothelial cell monolayer. Higher expression of VEGF mRNA in this cell line might facilitate neovascularization at the site of metastasis, resulting in extremely high metastatic potency after i.v. injection. LM8 also showed a high metastatic incidence (7/7) to the lung even after s.c. transplantation into the back space of mice. This cell line can provide an excellent tool for studying inhibitory agents against pulmonary metastasis as well as the various important factors involved in metastasis of osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579581     DOI: 10.1002/(sici)1097-0215(19980504)76:3<418::aid-ijc21>3.0.co;2-5

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  71 in total

1.  Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors.

Authors:  V Wallenius; M Hisaoka; K Helou; G Levan; N Mandahl; J M Meis-Kindblom; L G Kindblom; J O Jansson
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Effect of the histone deacetylase inhibitor SNDX-275 on Fas signaling in osteosarcoma cells and the feasibility of its topical application for the treatment of osteosarcoma lung metastases.

Authors:  Nadezhda V Koshkina; Krithi Rao-Bindal; Eugenie S Kleinerman
Journal:  Cancer       Date:  2011-02-01       Impact factor: 6.860

3.  Mesenchymal mode of migration participates in pulmonary metastasis of mouse osteosarcoma LM8.

Authors:  Yoshihiro Yui; Kazuyuki Itoh; Kiyoko Yoshioka; Norifumi Naka; Motonobu Watanabe; Yoshimi Hiraumi; Hiroshi Matsubara; Ken-ichiro Watanabe; Kazumi Sano; Tatsutoshi Nakahata; Souichi Adachi
Journal:  Clin Exp Metastasis       Date:  2010-09-26       Impact factor: 5.150

4.  Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis.

Authors:  Yasufumi Niinaka; Kiyoshi Harada; Masahiro Fujimuro; Masamitsu Oda; Arayo Haga; Misa Hosoki; Narikazu Uzawa; Naoya Arai; Satoshi Yamaguchi; Masashi Yamashiro; Avraham Raz
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

5.  Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases.

Authors:  Jun Yuan; Christian Ossendorf; Jan P Szatkowski; James T Bronk; Avudaiappan Maran; Michael Yaszemski; Mark E Bolander; Gobinda Sarkar; Bruno Fuchs
Journal:  Cancer Invest       Date:  2009-05       Impact factor: 2.176

6.  Cytoplasmic and/or nuclear staining of beta-catenin is associated with lung metastasis.

Authors:  Keiichi Iwaya; Hitoshi Ogawa; Masahiko Kuroda; Miki Izumi; Tsuyoshi Ishida; Kiyoshi Mukai
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

7.  p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

Authors:  Yiting Li; Manjula Nakka; Aaron J Kelly; Ching C Lau; Mark Krailo; Donald A Barkauskas; John M Hicks; Tsz-Kwong Man
Journal:  Cancer Res       Date:  2016-04-19       Impact factor: 12.701

8.  Effect of troglitazone on tumor growth and pulmonary metastasis development of the mouse osteosarcoma cell line LM8.

Authors:  Junichi Aizawa; Kenshi Sakayama; Setsuya Kamei; Teruki Kidani; Haruyasu Yamamoto; Yoshiaki Norimatsu; Hiroshi Masuno
Journal:  BMC Cancer       Date:  2010-02-22       Impact factor: 4.430

9.  Cytokine-based log-scale expansion of functional murine dendritic cells.

Authors:  Yui Harada; Yasuji Ueda; Hiroaki Kinoh; Atsushi Komaru; Terumi Fuji-Ogawa; Aki Furuya; Akihiro Iida; Mamoru Hasegawa; Tomohiko Ichikawa; Yoshikazu Yonemitsu
Journal:  PLoS One       Date:  2009-08-18       Impact factor: 3.240

10.  Characterization of STAT3 activation and expression in canine and human osteosarcoma.

Authors:  Stacey L Fossey; Albert T Liao; Jennifer K McCleese; Misty D Bear; Jiayuh Lin; Pui-Kai Li; William C Kisseberth; Cheryl A London
Journal:  BMC Cancer       Date:  2009-03-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.